Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Partners III L. P. Galen currently holds 11,482,379 shares of ACURA PHARMACEUTICALS, INC (ACUR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Partners III L. P. Galen has been a net seller of ACUR stock. They have purchased $0 and sold $3.5M worth of shares.
Partners III L. P. Galen's most recent insider trade was on Dec 14, 2017, when they sold 2,195,734 shares at $0.10 per share.
Partners III L. P. Galen serves as Executive at ACURA PHARMACEUTICALS, INC (ACUR). They have executed 18 insider transactions totaling $3.5M over their tenure at the company.
Partners III L. P. Galen holds the position of Executive at ACURA PHARMACEUTICALS, INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 22 years and currently hold a stake valued at $0.
Partners III L. P. Galen has shown a selling trading pattern, with $0 in total purchases and $3.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Partners III L. P. Galen was on Nov 3, 2006, when they sold $60.4M worth of ENMC shares. This transaction involved 9,216,431 shares at $6.55 per share.
Partners III L. P. Galen currently owns 11,482,379 shares of ACURA PHARMACEUTICALS, INC (ACUR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Partners III L. P. Galen's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Partners III L. P. Galen has 18 Form 4 filings on record as an insider at ACURA PHARMACEUTICALS, INC.
Set alerts for Partners III L. P. Galen and 40,000+ other insiders.